Development of molecular diagnostic test for early onset of lyme disease
Ended Project Grant Awarded Last action
- Award ID
- R44AI114009
- Recipient
-
Bioscience Development Inc. UEI TRCELQ72NMC3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,346,762
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- New York, NY 10128, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$639,694 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $998,043 | |
| Amendment | $0 | |
| Amendment | $1,000,000 | |
| Original award | $988,413 |
Quick answers
Who received award R44AI114009?
R44AI114009 was awarded to Bioscience Development Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 7, 2015.
How much is award R44AI114009 worth?
$2,346,762 has been obligated on R44AI114009.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award